Search results for: 'cell ad gene therapeutics market'

Organic solar cells (OSCs) are emerging as one of the more versatile photovoltaic technologies inthe third-generation solar cell technology domain, owing to their unique characteristics of flexibility, ultralightweight form factors, low-temperature processing, and compatibility with high-throughput printing techniques. Advancements in donor–accepto...

Energy decentralization, supportive regulations and policies, greater focus on sustainability, and the crucial development of a hydrogen economy will drive the stationary fuel cell industry growth during the next decade. The broader market for decentralized energy solutions thrives as residential, commercial, and industrial customers seek greater e...

08 Sep 2025  |  Global  |  Market Research

Growth Opportunities in Global Protein and Peptide Therapeutics, Forecast to 2030

Cross-Therapeutic Expansion is Driving Transformational Growth Fueled by Novel Formats and Smarter Delivery

Infographics

×

The protein and peptide therapeutics industry is undergoing a profound transformation, driven by next-generation biologics, including multi-specific antibodies, antibody-drug conjugates (ADCs), and GLP-1 treatments. These advances are intensifying competition, while the patent expiries of blockbuster antibodies are accelerating the entry of biosimi...

16 Jan 2025  |  Global  |  Technology Research

Advanced Therapeutics for the Infectious Disease Management Market, Global, 2024-2029

The emergence of novel pathogens and the reemergence of old pathogens are driving transformational growth by pushing therapeutic advancement.

Infographics

×

Antimicrobial resistance (AMR), the emergence of new pathogens, and breakthroughs in biotechnology have significantly transformed the global landscape of infectious diseases. This Frost & Sullivan report focuses on advanced therapeutics for the infectious disease management industry. It offers an analysis of clinical trials for 3 treatment modaliti...

There have been increasing incidences of rare ophthalmic diseases (e.g., retinitis pigmentosa, Stargardt disease, Leber congenital amaurosis) and prevalent diseases (e.g., age-related macular degeneration [AMD], geographic atrophy). While clinicians have used small molecules as the conventional therapeutic modality to manage these diseases, the urg...

15 May 2025  |  Global  |  Market Research

Immunomodulator Therapeutics Market, Global, 2024–2030

Mechanism-targeted Approaches are Driving Transformational Growth by Enabling Innovation in Autoimmune, Oncology, and Inflammatory Therapies

Infographics

×

This research service offers a comprehensive analysis of the global immunomodulator therapeutics market, specifically targeting inflammatory disorders in the immunology, gastrointestinal (GI), and dermatology segments. The report defines this market through products designed to modify and regulate pathological immune responses, either by inhibiting...

Stem cell therapeutics are being developed in order to fill the gaps in medical care and offer beneficial treatments for diseases that are currently inadequately treated or for which no therapeutic options exist. The stem cell therapeutics market is still in its infancy; currently, there are no licensed stem cell products in the United States. Thi...

This research identifies some the key developments across CAR-T cell therapies and provides insights across technological, IP, and investment landscapes. The study also provides an analysis of the competitive landscape while highlighting the key growth opportunities within the CAR-T cell therapy platform.

RNA therapeutics is a rapidly expanding field of next-generation medicine. RNA therapy typically comprises 4 different classes of molecules: non-codingRNA (ncRNA), antisense oligonucleotide (ASO), messengerRNA (mRNA), and RNA aptamer. Small ncRNAs are like a double-edged sword; they can either up- or down-regulate specific genes. Contrarily, long...